###begin article-title 0
Modulation of NKT Cell Development by B7-CD28 Interaction: An Expanding Horizon for Costimulation
###end article-title 0
###begin p 1
Conceived and designed the experiments: XZ YL PZ. Performed the experiments: XZ HZ LY. Analyzed the data: XZ YL PZ. Contributed reagents/materials/analysis tools: CRW. Wrote the paper: XZ YL PZ.
###end p 1
###begin p 2
###xml 237 238 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 257 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 568 569 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 574 575 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 633 634 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 639 640 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
It has been demonstrated that the development of NKT cells requires CD1d. The contribution of costimulatory molecules in this process has not been studied. Here we show that in mice with targeted mutations of B7-1/2 and CD28, the TCRbeta+alpha-Galcer/CD1d + (iValpha14 NKT) subset is significantly reduced in the thymus, spleen and liver. This is mainly due to decreased cell proliferation; although increased cell death in the thymi of CD28-deficient mice was also observed. Moreover, in the B7-1/2- and CD28-deficient mice, we found a decreased percentage of the CD4-NK1.1+ subset and a correspondingly increased portion of the CD4+NK1.1- subset. In addition, the mice with a targeted mutation of either B7 or CD28 had a reduced susceptibility to Con A induced hepatitis, which is known to be mediated by NKT cells. Our results demonstrate that the development, maturation and function of NKT cell are modulated by the costimulatory pathway and thus expand the horizon of costimulation into NKT, which is widely viewed as a bridge between innate and adaptive immunity. As such, costimulation may modulate all major branches of cell-mediated immunity, including T cells, NK cells and NKT cells.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 93 96 93 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Norton1">[1]</xref>
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Harding2">[3]</xref>
###xml 232 235 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Carreno1">[4]</xref>
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Ramarathinam1">[5]</xref>
###xml 472 475 472 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Bai1">[7]</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Chang1">[8]</xref>
###xml 505 508 505 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Dong1">[9]</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Zheng1">[10]</xref>
###xml 946 950 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Gao1">[11]</xref>
The notion of costimulation was proposed as the signal 2 for the activation of T lymphocytes [1]-[3]. Over the last two decades, B7 and CD28 families have emerged as the prototypical costimulatory ligands and receptors respectively [4]. Although the main emphasis in the field has been on the role of these interactions in the activation of T cells, accumulating data have demonstrated that this pathway also modulates effector function of T cells in cancer rejection [5]-[7] and autoimmune diseases [8], [9]. Moreover, clear evidence has been reported that support an important role for costimulation in the development of T cells [10]. Thus, the costimulatory pathway can in fact function through the whole life-span of T cells. Another interesting development in the field is that the costimulatory molecules ascribed to T cell immunity also modulate innate NK cell immune responses, including both expansion and effector function of NK cells [11]. An interesting issue is whether costimulation modulates the NKT subset, which is generally viewed as the bridge between innate and adaptive immunity.
###end p 4
###begin p 5
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Taniguchi1">[12]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kronenberg1">[16]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Bendelac1">[14]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kronenberg1">[16]</xref>
###xml 630 634 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Bendelac2">[15]</xref>
###xml 636 640 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kronenberg1">[16]</xref>
###xml 677 678 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 685 686 653 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 689 690 657 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 824 828 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Matsuda1">[17]</xref>
###xml 830 834 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Stetson1">[18]</xref>
###xml 912 916 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-VanDommelen1">[19]</xref>
###xml 927 931 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Swann1">[20]</xref>
###xml 958 962 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-VanKaer1">[21]</xref>
###xml 431 436 <span type="species:ncbi:10090">mouse</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
NKT cells are a unique subset of T cells expressing both TCR and NK cell markers [12]-[16]. However, unlike NK cells, NKT cells mainly develop in the thymus. In contrast to conventional T cells, NKT cells respond to antigen presented by the nonpolymorphic major histocompatibility complex (MHC) Class I-like molecule CD1d [14]-[16]. The TCR of a major subset of NKT cells is composed almost exclusively of Valpha14/Jalpha18 in the mouse and Valpha24/Jalpha18 in human. In mice the TCR receptor alpha chain is paired with the Vbeta8.2, Vbeta7, or Vbeta2 TCRbeta chain. This subset recognize glycolipids presented by CD1d molecules [15], [16]. Almost all NKT cells are either CD4+ or CD4-CD8- (DN). Upon stimulation through their TCR, the NKT cells rapidly produce substantial amounts of cytokines, such as IL-4 and IFN-gamma [17], [18]. Emerging data demonstrate that it is involved in immunity against infection [19] and tumor [20] and in autoimmune disease [21] by either direct cytotoxicity or secretion of several cytokines.
###end p 5
###begin p 6
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-MacDonald1">[22]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-MacDonald2">[23]</xref>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Gapin1">[24]</xref>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 740 741 740 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci1">[25]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci2">[27]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Gapin1">[24]</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Chun1">[28]</xref>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
###xml 1265 1269 <span type="species:ncbi:10090">mice</span>
The developmental relationship between NKT and conventional T cells has been controversial. Two models have been proposed for NKT cell development [22], [23]. NKT cells might derive from a distinct precursor that undergoes lineage commitment independently of TCR-ligand interactions (pre-committed model). Alternatively, they may develop as a byproduct of conventional T cell development at a certain stage, depending on the ligand they recognize (TCR-instruction model). Recently, by intrathymic injection, Gapin et al. showed that NKT cells can be produced in the thymus from CD4+CD8+ DP thymocyte [24]. An intermediate, semi-mature CD4+NK1.1- stage has been proposed before NKT cells finally develop into NK1.1+ cells that are either CD4+ or double negative [25]-[27]. Moreover, the positive and negative selection of NKT cells rely on CD1d being presented by hematopoietic derived DP thymocyte or dendritic cells, respectively [24], [28], but not those presented by thymic epithelial cells. The details of this selective process are still largely unknown. A largely unresolved issue is whether the B7-CD28 interaction is involved in the development of NKT cells. In order to address this question, we compared the development of NKT cells in WT mice to that in mice with targeted mutations of B7-1/B7-2 or CD28. Our results demonstrate that the development and function of NKT cells are subject to modulation by costimulatory pathways.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 20 21 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 26 27 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
The reduced TCR beta+NK1.1+ NKT cells in B7-1/2 and CD28 deficient mice
###end title 8
###begin p 9
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 333 334 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 354 361 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g001">Fig. 1A</xref>
###xml 371 372 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 377 378 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 564 565 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 568 569 562 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 603 607 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Bendelac2">[15]</xref>
###xml 637 638 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 642 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
In order to evaluate the role for costimulatory molecules on NKT development, we compared the percentages of NKT cells in the central and peripheral lymphoid organs of B7-1/2, CD28 mutant mice with those of NKT cells in the same organs of age and sex- matched WT mice. In this study, the total NKT cells were defined as NK1.1+TCRbeta+ cells. As shown in Fig. 1A, TCR beta+NK1.1+ cells comprise about 1% of the total thymocytes in WT mice. After dividing the thymocytes into DN, DP and SP subsets, it was clear that NKT cells were largely absent from the DP and CD4-CD8+ subsets, as others have reported [15]. About 5% of DN and 4% of CD4+CD8- thymocytes expressed the NKT marker in WT mice. A 3-5 fold reduction of the NKT cells was observed in total thymocytes and DN and CD4 subsets from both B7-1/2- and CD28- deficient mice. Thus, B7-CD28 interaction is required for the development of NKT in the thymus.
###end p 9
###begin title 10
###xml 65 66 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 72 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Roles for B7-1/2-CD28 interaction in the accumulation of TCR beta+NK1.1+ NKT cells in the thymus (A), spleen (B) and liver (C).
###end title 10
###begin p 11
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 433 434 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
B7KO, CD28KO and WT C57BL/6 mice were sacrificed at 8-week of age. Total lymphocytes (left column) from viable cells, CD4-CD8- DN lymphocytes (middle column) and CD4+ lymphocytes (right column) were analyzed for the expression of TCRbeta and NK1.1. One representative profile from each group is presented. The numbers in the panels are percentages (Mean+/-SD) of gated NKT cells (n = 9). The numbers shown on the side of figures are p value between two indicated groups.
###end p 11
###begin p 12
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g001">Fig. 1B</xref>
###xml 164 165 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 170 171 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 278 279 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 454 458 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Emoto1">[29]</xref>
###xml 459 463 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Exley1">[31]</xref>
###xml 519 520 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 523 524 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 648 649 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 654 655 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 667 674 661 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g001">Fig. 1C</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
We also compared the amounts of NKT cells in the spleens and livers of mice deficient for B7-1/2 and CD28 with those of WT mice. As shown in Fig. 1B, total TCR beta+NK1.1+ cells in the spleen were decreased somewhat as a result of targeted mutation of B7 and CD28. Among the CD4+ splenocytes, the NKT subset is reduced by more than 2-fold. However, the reduction in DN NKT was marginal. The liver is known to be populated with a high number of NKT cells [29]-[31]. However, except for the reduction in NKT among the CD4+CD8- subset in the CD28 deficient mice, targeted mutation of B7-CD28 did not have a significant impact on the number of TCR beta+NK1.1+ NKT cells (Fig. 1C).
###end p 12
###begin p 13
###xml 207 211 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Eberl1">[32]</xref>
###xml 213 217 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Hammond1">[33]</xref>
###xml 499 503 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kawano1">[34]</xref>
###xml 747 748 715 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 755 756 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 763 767 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Benlagha2">[35]</xref>
###xml 769 773 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Matsuda2">[36]</xref>
###xml 967 968 928 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 987 991 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-MacDonald2">[23]</xref>
###xml 1065 1066 1023 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1071 1072 1029 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1126 1132 1084 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g002">Fig. 2</xref>
###xml 1159 1160 1114 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1165 1166 1120 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1286 1287 1234 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1292 1293 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1521 1522 1462 1463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1527 1528 1468 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1596 1597 1534 1535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1602 1603 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
###xml 1435 1439 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
###xml 1624 1628 <span type="species:ncbi:10090">mice</span>
###xml 1752 1756 <span type="species:ncbi:10090">mice</span>
Most of the NKT cells recognize glycolipids presented by MHC class I-like molecule CD1d, and are referred to as iValpha14 NKT cells for being CD1d-restricted NKT bearing the invariant Valpha14 rearrangement [32], [33]. Although the identity of the endogenous antigen presented by CD1d is still unclear, a synthetic glycolipid antigen derived from marine sponges called alpha-galactosyl ceramide (alpha-GalCer) can be recognized by NKT and potently stimulate NKT cells via TCR when presented by CD1d [34]. Recently, the development of alphaGalCer/CD-1d tetramer, which recognizes invariant Valpha14-Jalpha281 TCR, provides another powerful tool to identify iValpha14 NKT cells. alphaGalCer/CD-1d tetramer positive cells comprised about 80% of NK1.1+TCRbeta+ cells [35], [36]. Those alphaGalCer/CD-1d tetramer negative cells were identified as different subsets of NKT cells, which are preferentially localized in spleen and bone marrow and are predominantly of the CD8+ (or DN) phenotype [23]. In this study, we used the tetramer to further characterize the TCR beta+NK1.1+ cells in B7-1/2 and CD28 deficient mice. As shown in Fig. 2, about 90% of the TCR beta+NK1.1+ cells in WT thymus bind to alpha-GalCer-CD1d tetramer. In B7- and CD28- deficient thymus only about 75% of the TCR beta+NK1.1+ NKT bind to the tetramer. The reduction of the alpha-GalCer-CD1d tetramer binding cells in the spleen and liver is more severe in the mutant mice. Whereas in WT mice, there were close to 50% of spleen and liver derived TCR beta+NK1.1+ NKT cells that bound to the tetramer, and less than 20% of TCR beta+NK1.1+ NKT cells in mutant mice showed similar specificity in the spleen, and the tetramer binding cells were reduced by 2-fold in the liver of the mutant mice.
###end p 13
###begin title 14
###xml 49 50 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 55 56 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
Proportions of iValpha14 NKT cells among TCR beta+NK1.1+ cells isolated from the thymus, spleen and liver of WT, B7-1/2 and CD28 deficient mice.
###end title 14
###begin p 15
###xml 292 293 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 315 316 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 321 322 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 438 439 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
Total lymphocytes from the thymus (left), spleen (middle) and liver (right) of 8-week old WT (top), B7-1/2- (center) and CD28- (bottom) deficient mice were stained with TCRbeta, NK1.1 and alpha-GalCer/CD1d tetramer. The numbers represent the percentage (Mean+/-SD, n = 9) of alpha-GalCer/CD1d+ cells in the TCR beta+NK1.1+ population. One representative profile from each group is shown here. The numbers shown on the side of figures are p value between two indicated groups.
###end p 15
###begin title 16
B7-CD28 interaction promotes expansion of NK1.1 on the iValpha14 NKT cells
###end title 16
###begin p 17
###xml 225 232 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g003">Fig. 3A</xref>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
To further characterize the effect of costimulatory molecules on iValpha14 NKT cell development and activation, we analyzed the number of cells as well as NK1.1, CD44 and CD4 expression among iValpha14 NKT cells. As shown in Fig. 3A, the number of iValpha14 NKT cells was significantly reduced in total lymphocytes from both the thymus and spleen of B7-1/2 deficient mice. Again, a qualitatively similar but quantitatively more significant reduction was detected in CD28 deficient mice. While a small reduction was observed in the liver of B7- deficient mice, no reduction of iValpha14 NKT was observed in the liver of CD28-deficient mice. Thus, the optimal production of iValpha14 NKT cells in the thymus and their accumulation in the spleens require B7-CD28 interaction.
###end p 17
###begin title 18
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Quantitative and phenotypic variation of iValpha14 NKT cells in the thymus, spleen and liver of WT, B7-1/2 and CD28 deficient mice.
###end title 18
###begin p 19
###xml 420 421 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 567 568 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 571 572 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 595 596 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 599 600 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 739 740 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
Total lymphocytes from the thymus (left), spleen (middle) and liver (right) of 8-week old WT (top), B7-1/2 (center) and CD28 (bottom) deficient mice were analyzed. A. The quantification of iValpha14 NKT cells. The numbers represent the percentage (Mean+/-SD, n = 9) of iValpha14 NKT cells. B. The expression of CD44 and NK1.1 among the gated iValpha14 NKT cells. The numbers represent the percentage (Mean+/-SD) of NK1.1- iValpha14 NKT cells. C. The expression of CD4 and NK1.1 from gated iValpha14 NKT cells. The numbers represent the percentage (Mean+/-SD) of NK1.1-CD4+ (upper left) and NK1.1+CD4- (lower right) iValpha14 NKT cells. One representative profile from each group is shown here. The numbers shown on the side of figures are p value between two indicated groups.
###end p 19
###begin p 20
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 109 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 204 205 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 282 283 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 381 388 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g003">Fig. 3B</xref>
###xml 471 472 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 475 476 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 483 484 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 487 488 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 498 499 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 502 503 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 614 615 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 618 619 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 668 669 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 672 673 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 682 689 666 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g003">Fig. 3C</xref>
###xml 796 797 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 942 943 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 987 994 959 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002703-t001">Table 1</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 838 842 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
Recent studies have demonstrated that in normal mice the NK1.1+ iValpha14 NKT cells are developed from NK1.1- iValpha14 NKT cells. Interestingly, in B7-1/2 and CD28 deficient mice, the percentage of NK1.1+ subsets among iValpha14 NKT cells was significantly reduced, while the NK1.1- subsets were significantly increased by 4-fold in the thymus and 2-fold in the spleen and liver (Fig. 3B). The iValpha14 NKT cells could be further divided into three major subsets, NK1.1-CD4+, NK1.1+CD4+ and NK1.1+CD4-. Compared to wild type mice, targeted mutation of both B7 and CD28 caused a significant reduction in the NK1.1-CD4+ subset and a corresponding increase in the NK1.1+CD4- subset (Fig. 3C). If the reduction of iValpha14 NKT cells from total lymphocytes is considered, the reduction of the NK1.1+ iValpha14 NKT subset seen in the mutant mice is even more significant when compared to WT mice, and the seemingly observed increase in the NK1.1-iValpha14 NKT subset is actually unchanged (Table 1).
###end p 20
###begin title 21
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Different iValpha14 NKT subsets in total lymphocytes of thymus, spleen and liver in WT, B7-1/2 and CD28 deficient mice.
###end title 21
###begin p 22
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
Lymphocytes from thymus, spleen and liver of age and sex-matched WT, B7-1(-/-)/B7-2(-/-) or CD28(-/-) mice were analyzed by flow cytometry. The iValpha14 NKT cells were identified based on expressing TCRbeta and binding to the alpha-Galcer/CD1d tetramer. Data shown are means and SD of the percentage of given subsets in total viable lymphocytes (n = 4). Similar data were obtained in another experiment involving 5 mice per group.
###end p 22
###begin p 23
P<0.05,
###end p 23
###begin p 24
P<0.01,
###end p 24
###begin p 25
P<0.001.
###end p 25
###begin title 26
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Normal generation of immature iValpha14 NKT cells in young B7- and CD28-deficient mice
###end title 26
###begin p 27
###xml 128 132 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kronenberg1">[16]</xref>
###xml 134 138 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci2">[27]</xref>
###xml 268 272 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Gapin1">[24]</xref>
###xml 274 278 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci2">[27]</xref>
###xml 501 508 481 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g004">Fig. 4A</xref>
###xml 742 746 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci2">[27]</xref>
###xml 913 914 889 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 921 922 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 929 933 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci2">[27]</xref>
###xml 1145 1152 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g004">Fig. 4B</xref>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
In the thymus, a low number of iValpha14 NKT cells can be detected by alpha-GalCer/CD1d tetramer as early as 5 days after birth [16], [27]. Thereafter, both the percentage and the absolute number of iValpha14 NKT cells increase reaching a peak level at around 6 weeks [24], [27]. To determine if B7-CD28 interaction is required for the generation of iValpha14 NKT cells in young mice, we analyzed the number and phenotypes of iValpha14 NKT cells in the thymi and livers of 8-day old mice. As shown in Fig. 4A, the total percents of tetramer binding cells in WT and mutant mice were only around 0.03% in the thymus and 0.2% in the liver. Both the number and the pattern of NK1.1 and CD4 are consistent with that previously observed in WT mice [27]. Pellicci et al. also demonstrated that at day11 of fetal thymus organ culture FTOC, alpha-GalCer/CD1d tetramer NKT cells only account for less than 5% of total NK1.1+TCRbeta+ cells [27]. Therefore, the percentage of total NKT cells at 8 days of age should be more than the above numbers. In all strains of mice, the majority of iValpha14 NKT cells were immature as they did not yet express NK1.1 (Fig. 4B). Thus, B7-CD28 interaction appears selectively involved in the maturation of NKT cells in adult mice.
###end p 27
###begin title 28
###xml 96 100 <span type="species:ncbi:10090">mice</span>
B7- and CD28-deficiency does not affect the generation of immature iValpha14 NKT cells in young mice.
###end title 28
###begin p 29
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Total lymphocytes from the thymus (upper panel) and liver (lower panel) of 8-day old WT (left), B7-1/2- (middle) and CD28- (right) deficient mice were analyzed. The numbers represent the percentage (Mean+/-SD, n = 4) of iValpha14 NKT cells (A) and the percentage (Mean+/-SD, n = 4) of individual subsets from gated iValpha14 NKT cells (B). One representative profile from each group is shown.
###end p 29
###begin title 30
B7-CD28 interaction promotes proliferation of NKT cells
###end title 30
###begin p 31
###xml 417 418 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 455 456 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 461 462 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 486 493 478 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g005">Fig. 5A</xref>
###xml 536 537 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 561 562 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 567 568 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 654 655 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 763 764 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
The reduced cell number can be explained by increased cell death and/or decreased cell proliferation in the organ. Therefore, we first tested whether B7 and CD28 deficiencies affect the survival of iValpha14 NKT cells. We compared the number of cells undergoing programmed cell death in WT, B7-1/2- and CD28-deficient mice by staining with Annexin V. Since the reduction of iValpha14 NKT cells is limited to the NK1.1+ subset, we analyzed apoptosis of TCR+NK1.1+ NKT cells. As shown in Fig. 5A, in WT mice, there were about 3% Annexin V+ cells in the thymic TCR+NK1.1+ cells and 20% in the same subsets from the spleen. While the same amount of Annexin V+ cells was detected in the thymus of B7-1/2 deficient mice, CD28-deficient mice had an increase in Annexin V+ cells in the thymus, but not in the spleen. Thus, while a contribution of CD28 in the survival of NKT cells in the thymus cannot be ruled out, decreased survival does not explain the defect in the development of iValpha14 NKT cells.
###end p 31
###begin title 32
B7-CD28 interaction promotes proliferation but not survival of NKT cells.
###end title 32
###begin p 33
###xml 358 359 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 365 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 549 556 541 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 751 752 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 742 747 <span type="species:ncbi:10090">mouse</span>
5-7-week old WT, B7KO, CD28KO mice received intravenous injection of BrdU. The lymphocytes from the thymus (top) and spleen (bottom) were harvested 4 hours later and stained with antibodies for TCRbeta, NK1.1 and BrdU or with Annexin V. A. NKT cells that underwent apoptosis. The numbers represent the percentages (Mean+/-SD) of apoptotic cells among TCRbeta+NK1.1+ cells and summarizing data from 2 independent experiments involving a total of 6 mice in the WT and CD28 mutant group, and 3 in B7-1/2 mutant mice. B. NKT cells undergo proliferation in vivo as revealed by incorporation of BrdU. The numbers in the panels indicate means and SD (n = 3) of the percentages of NKT cells that have incorporated BrdU in the thymus. FITC conjugated mouse IgG1, kappa was used as isotype control (right). One representative profile from each group is shown.
###end p 33
###begin p 34
###xml 174 175 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g005">Fig. 5B</xref>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
To investigate whether B7- and CD28-deficiencies affect the proliferation of NKT cells, we pulsed WT, B7- and CD28- deficient mice with BrdU and measured DNA synthesis in TCR+NK1.1+ by flow cytometry. As shown in Fig. 5B, about 10% of the TCR+NK1.1+ cells were undergoing proliferation in WT mice during the 4h period, the percentages of BrdU+ cells were reduced by 2 fold in B7-1/2 deficient mice and 4 fold in CD28 deficient mice in the thymus. A significant although less pronounced reduction was observed in the spleens of the mutant mice. The more significant inhibition of cell proliferation and somewhat increased cell death of NKT cells in the thymus might explain the more severe reduction of NKT cells in mice with targeted mutations of CD28.
###end p 34
###begin title 35
###xml 63 67 <span type="species:ncbi:10090">mice</span>
The defective NKT function in costimulatory molecule deficient mice
###end title 35
###begin p 36
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Takeda1">[37]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kaneko1">[38]</xref>
###xml 448 454 444 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g006">Fig. 6</xref>
###xml 709 716 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g006">Fig. 6A</xref>
###xml 849 862 845 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g006">Fig. 6B and C</xref>
###xml 94 100 <span type="species:ncbi:10090">murine</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
Several publications have demonstrated the contribution of liver NKT cells to a Con A induced murine hepatitis model [37], [38]. To explore if there is possible defective NKT function due to the reduction of iValpha14 NKT cells in B7 and CD28 deficient mice, we injected Con A into B7-1/2, CD28 deficient mice and WT mice and measured serum AST and ALT levels for liver damage. The liver sections were also examined after H&E staining. As shown in Fig. 6, severe liver damage was induced in WT mice as revealed by high serum AST and ALT levels and necrosis of hepatocytes. In the B7- and CD28- deficient mice, serum AST and ALT levels were reduced by more than 2-fold in mutant mice as compared with WT mice (Fig. 6A). Corresponding to this we also observed a 4-5-fold reduction in the necrotic area of the livers from B7- and CD28- deficient mice (Fig. 6B and C).
###end p 36
###begin title 37
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Con A induced hepatitis is alleviated in B7- and CD28- deficient mice.
###end title 37
###begin p 38
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Eight-week old B7KO, CD28KO and C57BL/6 mice received intravenous injection of Con A at a dose of 20 mg/kg. Sixteen hours later, serum and liver tissues from individual mice were harvested. A. Serum ALT and AST levels. B. One representative section from each group showing the pattern of liver injury. C. Average percentages of area with injuries from 3-4 sections per mouse and 4-5 mice per group.
###end p 38
###begin title 39
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Reduced level of Con A induced IFN-gamma production in B7-1/2 deficient mice
###end title 39
###begin p 40
###xml 96 100 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kusters1">[39]</xref>
###xml 101 105 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Naka1">[41]</xref>
###xml 133 137 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Takeda1">[37]</xref>
###xml 139 143 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kaneko1">[38]</xref>
###xml 145 149 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Jaruga1">[42]</xref>
###xml 297 301 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Jaruga1">[42]</xref>
###xml 303 307 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Louis1">[43]</xref>
###xml 317 321 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Sun1">[44]</xref>
###xml 539 546 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex vivo</italic>
###xml 612 619 608 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 633 640 629 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g007">Fig. 7A</xref>
###xml 859 860 855 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 867 868 860 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1209 1216 1202 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g007">Fig. 7B</xref>
###xml 1600 1604 1581 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Sass1">[45]</xref>
###xml 1606 1610 1587 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Hayakawa1">[46]</xref>
###xml 1869 1876 1846 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g007">Fig. 7C</xref>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
###xml 1432 1436 <span type="species:ncbi:10090">mice</span>
###xml 1712 1716 <span type="species:ncbi:10090">mice</span>
###xml 1954 1958 <span type="species:ncbi:10090">mice</span>
Con A induced hepatitis is a multiple factors disease process. Both Th1 type cytokine IFN-gamma [39]-[41] and Th2 type cytokine IL-4 [37], [38], [42] are crucially involved in the induction of NKT cell-mediated liver specific inflammation. Moreover, other immunoregulatory cytokines, such as IL-5 [42], [43] and IL-6 [44], had also been demonstrated to mediate the pathogenesis of this disease. We investigated whether the reduced susceptibility to Con A induced hepatitis in B7-1/2 deficient mice is due to defective cytokine production. Ex vivo mononuclear cells were analyzed at 6 hours after Con A treatment in vivo. As shown in Fig. 7A, compared with Non-treated mice, the percentage of total NKT cells was reduced almost 10-fold in in the livers of ConA treated WT and B7KO mice. Correspondingly, the conventional T cells, which were identified by NK1.1-TCRbeta+ cells are relatively increased. Interestingly, those NKT cells reside in the spleen are not affected. Comparable numbers of total NKT cells are detected before and after ConA treatment in the spleens of both strains. This further demonstrated that NKT cells in the liver play a major role inducing acute hepatitis. In addition, as shown in Fig. 7B, in WT mice, about 20% of he liver NKT cells produced IFN-gamma and 4% of the NKT cells produced high levels of IL-4. The amount of the same level of IFN-gamma producing cells was reduced by 50% in B7-1/2 deficient mice, while the amount of high levels of IL-4 producing cells was unchanged. It has been shown that the peak of IL-4 production by NKT cells is earlier than IFN- gamma [45], [46]. We also confirmed that B7-1/2 deficient NKT cells in the spleen produced less IL-4 compared with WT mice at an earlier time point (unpublished observation). However, both IFN-gamma and IL-4 cytokine secretions in conventional T cells are barely detectable (Fig. 7C), Therefore, reduced severity in Con A-induced hepatitis in the B7-deficient mice correlates to decreased IFN-gamma by NKT cells.
###end p 40
###begin title 41
###xml 52 53 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 58 59 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
The reduction of IFN-gamma production among TCR beta+NK1.1+ cells isolated from the liver of B7-1/2 deficient mice.
###end title 41
###begin p 42
###xml 389 390 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 398 399 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 432 433 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 442 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 584 585 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 593 594 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 668 669 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 677 678 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
Eight-week old WT (top) and B7-1/2- (bottom) deficient mice received intravenous injection of Con A (25mg/kg). The mice were sacrificed six hours later. After perfusion the total number of mononuclear cells from the liver and spleen were stained with TCRbeta, NK1.1, anti-mouse IFN-gamma or IL-4 mAbs, or fluorescence conjugated isotype control. A. The percentage of total NKT cells (NK1.1+TCR beta+) and conventional T cells (NK1.1+TCR beta+) in the spleen and liver from Non-treated (left) and ConA treated mice (right). B. The percentage of cytokine producing cells among the NK1.1+TCR beta+ population. C. The percentage of cytokine producing cells among the NK1.1-TCR beta+ population. The numbers represent the percentage (Mean+/-SD) of one representative profile from each group is shown. The experiment was repeated twice; 7-8 mice were included in each group. D. Cytokine secretion of purified CD4 T cells from WT and B7KO mice stimulated by KRN7000. The numbers represent the profile of purified CD4 T cells from 3 mice in each group. The experiment was repeated twice.
###end p 42
###begin p 43
###xml 309 313 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-IssaChergui1">[47]</xref>
###xml 450 457 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002703-g007">Fig. 7D</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
To further confirm the defect of NKT population in B7 mutant mice, we adopted an in vitro model to test the reactivity of NKT cells from WT and B7KO mice to its exogenous ligand, alpha-Galactosylceramide (KRN7000). To exclude the effect of weak costimulatory signaling from B7 mutant antigen presenting cells [47], both purified CD4 T cells from WT and B7KO mice was stimulated in vitro with purified CD11c+ dendritic cells from WT mice. As shown in Fig. 7D, after 48hours co-culture with KRN7000, CD4 T cells from WT have a stronger response, as indicated by more IFN-gamma and IL-4 secretion. Because KRN7000 can only be recognized by iValpha14 NKT cell in CD4 population, this result provided direct evidence of lower number and/or functional defect of NKT cells in B7KO mice.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 316 317 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 427 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 498 499 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 583 584 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 676 677 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 725 726 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 741 745 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Benlagha1">[26]</xref>
###xml 747 751 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Pellicci2">[27]</xref>
###xml 1055 1056 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1230 1234 <span type="species:ncbi:10090">mice</span>
By comparing WT mice with those with targeted mutations of CD28 or B7-1/2, we have demonstrated a major contribution of B7-CD28 interaction in the generation of iValpha14 NKT cells in the thymus. Two lines of evidence presented here suggest that B7-CD28 interaction is required for the expansion of more mature NK1.1+ iValpha14 NKT subsets. First, the number of iValpha14 NKT cells in young mice, which are predominantly NK1.1-, is unaffected by these mutations. Second, the overall number of NK1.1- iValpha14 NKT cell was largely unaffected in the mutant adult mice, while the NK1.1+ iValpha14 NKT cells were drastically reduced. Since earlier studies demonstrated that NK1.1- iValpha14 NKT cells are the precursors of NK1.1+ iValpha14 NKT [26], [27], our data indicated that B7-1/2-CD28 interaction is not required for the generation of NKT cell precursors. The co-stimulation-dependent expansion of mature NKT is largely due to a critical contribution of B7-CD28 interaction in proliferation of the NKT cells as the incorporation of BrdU into the NK1.1+ NKT cells was drastically reduced. However, the percentage of apoptotic cells was unchanged in the B7-1/2-deficient mice and only marginally increased in the CD28-deficient mice.
###end p 45
###begin p 46
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
###xml 1174 1178 <span type="species:ncbi:10090">mice</span>
###xml 1287 1291 <span type="species:ncbi:10090">mice</span>
###xml 1322 1326 <span type="species:ncbi:10090">mice</span>
As a consequence of defective NKT maturation in the thymus, we observed a significant reduction of the mature NKT cells in the spleen and liver, the major residences of the NKT cells. Nevertheless, the defects in the periphery were somewhat less pronounced than what was observed in the thymus. Theoretically, this can be due to increased emigration from the thymus, increased survival and increased proliferation in the mutant mice. We have not observed increased proliferation of NKT in the periphery of the mutant mice. In fact, we have observed decreased proliferation of NKT in the mutant mice. However, we have observed a decreased apoptosis of NKT cells in the spleens of B7-deficient mice. A similar trend was also observed in the CD28-deficient mice. The increased survival explains the lack of 1:1 correlation between the reduction in the thymus and that in the spleen and liver. Another unexplained observation is the more severe phenotype observed in CD28-deficient mice as compared to B7-deficient mice. Since B7-1/2 interacts with both CD28 and CTLA-4, it is theoretically possible to explain the discrepancies between B7-1/2-deficient mice and CD28-deficient mice by invoking an opposite function of these two receptors. The fact that the deficiency was observed in older mice and that the CTLA-4-deficient mice do not survive to adulthood have made it difficult to test this hypothesis.
###end p 46
###begin p 47
###xml 268 273 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 275 278 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 287 290 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 362 366 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Takeda1">[37]</xref>
###xml 368 372 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kaneko1">[38]</xref>
###xml 374 378 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Diao1">[48]</xref>
###xml 509 512 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gld</italic>
###xml 545 549 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Takeda1">[37]</xref>
###xml 804 805 800 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 980 984 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Takeda1">[37]</xref>
###xml 986 990 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Kaneko1">[38]</xref>
###xml 992 996 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Jaruga1">[42]</xref>
###xml 1207 1211 1199 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Sass1">[45]</xref>
###xml 1213 1217 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Hayakawa1">[46]</xref>
###xml 1259 1260 1247 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1469 1473 1445 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Takeda1">[37]</xref>
###xml 1526 1530 1502 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Eberl2">[40]</xref>
###xml 1647 1651 1623 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Naka1">[41]</xref>
###xml 1693 1694 1669 1670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 1780 1784 <span type="species:ncbi:10090">mice</span>
Concanavalin A-induced (ConA-induced) hepatitis in mice is a well-characterized model of T cell-mediated inflammatory liver disease. Recently, it has been demonstrated that invariant NKT (iNKT) cells play a key role in the development of ConA-induced hepatitis. Both Jalpha18-/- and CD1d-/- mice that lack iNKT cells are resistant to ConA-induced hepatic injury [37], [38], [48]. In addition, the adoptive transfer of hepatic mononuclear cells from wild-type mice, but not from CD1-deficient mice, sensitized gld mice to Con A-induced hepatitis [37]. The later results demonstrated that NKT cell, other than other cell, is the major mediator of the disease process. Here we demonstrated that the B7-1/2- and CD28-deficient mice are more resist to the disease. In this model, IL-4 secreted by mainly NK1.1- iValpha14 NKT cells, was demonstrated to play a crucial role in causing NKT cells to express FasL and to contribute to Fas/FasL-mediated liver injury in an autocrine fashion [37], [38], [42]. Although our presented data appear to refute a role for IL-4 production by NKT cells, this is likely due to the fact that the data presented was obtained at 6 hours when the peak of IL-4 production had weaned [45], [46]. In addition, IFN-gamma produced by NK1.1+ iValpha14 NKT cells is also very important in mediating the disease process. IFN-gamma can activate resident Kupffer cells and recruit macrophages to produce TNF-alpha, which subsequently causes liver injury [37], induces proliferation and cytotoxicity of NK cells [40] and regulates IL-4 signaling as well as its own signaling through induced suppressor of cytokine signaling (SOCS-1) [41]. Thus, the significant reduction of NK1.1+ iValpha14 NKT cells may alleviate Con A-induced hepatitis in B7- and CD28- deficient mice by abrogating the production of IFN-gamma. This hypothesis is supported by our analysis of ex vivo NKT cells, which revealed reduced IFN-gamma producing cells following in vivo Con A stimulation.
###end p 47
###begin p 48
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Frauwirth1">[49]</xref>
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Ramarathinam1">[5]</xref>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Bai1">[7]</xref>
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Chang1">[8]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Zheng1">[10]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Gao2">[50]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Gao1">[11]</xref>
Costimulatory pathways were traditionally viewed as critical modulators for the induction of T cell responses in peripheral lymphoid organs [49]. Subsequent studies in tumor [5]-[7] and autoimmune disease [8] models have revealed a critical contribution to the effector phase of T-cell immunity. More recent studies expand its contribution to differentiation of immature thymocytes and negative selection of T cells [10], [50]. In addition, the function of costimulatory molecules may extend beyond adaptive immunity, as several groups have suggested a role for the activation of NK cells [11]. Our data presented here demonstrate a role for T cell costimulation in both the development and function of NKT cells, which is widely regarded as a bridge between adaptive and innate immunity. Taken together, it is possible that costimulatory molecules modulate all major branches of cell-mediated immunity, including T cells, NK cells and NKT cells.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
Experimental animals
###end title 50
###begin p 51
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">Mice</span>
Wild-type C57BL/6j, B7-1/2 double knockout and CD28 knockout mice on C57BL/6j background were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Different strains of Mice were maintained in the University Laboratory Animal Research Facility at The Ohio State University and The University of Michigan under specific-pathogen-free conditions. All animal experimental procedures were reviewed and approved by The Ohio State University and University of Michigan Institutional Animal Care and Use Committees.
###end p 51
###begin title 52
Cell Preparation
###end title 52
###begin p 53
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 343 344 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Single cell suspensions from the thymus and spleen were prepared by mechanical disruption in cold, serum free RPMI 1640 medium. The liver was perfused with 1xPBS via portal vein. Then, the liver fragments were incubated with 1mg/ml Collagenase type IV (Sigma, C5138) in 10mM Hepes-NaOH buffer (150 mM NaCl, 5 mM KCl, 1 mM MgCl2 and 1.8 mM CaCl2, pH 7.4) for 1 h at 37degreesC and gently dissociated. The whole material was passed through a syringe several times to get a single cell suspension. The liver mononuclear cells were recovered from the interface of 40% and 60% percoll after centrifugation. Red blood cells from single cell suspensions were removed by brief hypotonic lysis before cell surface staining.
###end p 53
###begin title 54
Antibodies and flow cytometry
###end title 54
###begin p 55
###xml 429 433 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Chun1">[28]</xref>
###xml 435 439 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002703-Matsuda2">[36]</xref>
Both cell surface markers and intracellular staining were analyzed by flow cytometry (Becton Dickinson, Mountain View, CA). The fluorescein-conjugated antibodies anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-TCR beta chain (H57-597), anti-CD44 (IM7), anti-CD25 (PC61) and anti-NK1.1 (PK136) were purchased from BD PharMingen (San Diego, CA, USA). Phycoerythorin-conjugated alpha-GalCer loaded CD1d tetramer was prepared as described [28], [36]. The fixation and permeabilization solution kit (Cytofix/Cytopermtrade mark, BD Pharmingen) was used for intracellular staining according to the manufacturer's protocol. The samples were analyzed by flow cytometry. Data acquisition was performed on a FACSCalibur instrument with CELLQUEST software (Biosciences, Mountain View, CA), and data were analyzed using FLOWJO software (Tree Star, Inc., Ashland, OR).
###end p 55
###begin title 56
Cell death and proliferation assay
###end title 56
###begin p 57
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 403 408 <span type="species:ncbi:10090">mouse</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
The apoptotic lymphocytes were determined by their binding to Annexin V. After cell-surface staining, the cells were resuspended in Annexin V (BD PharMingen), dissolved in 10 mM Hepes, 140mM NaCl, 2.5mM CaCl2 and stained at room temperature for 15 minutes and then analyzed within an hour. To measure the proliferation of lymphocytes in vivo, mice were injected intraperitoneally (i.p.) with BrdU (1 mg/mouse in 100 microl PBS). Four hours later, the mice were sacrificed and single lymphocytes were prepared. BrdU incorporation was detected by flow cytometry with a BrdU Flow Kit, as described by manufacturer (BD PharMingen).
###end p 57
###begin title 58
Induction of ConA induced hepatitis
###end title 58
###begin p 59
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
Con A (Sigma, C0412) was dissolved in pyrogen-free PBS and i.v. injected into mice through the tail vein at a dose of 20mg/kg. Sera from individual mice were obtained 16 h after Con A injection. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured by the standard photometric method using Hitachi type 911 automatic analyzer (Tokyo). 25mg/kg Con A was used for short-term stimulation, and the splenocytes and hepatocytes were harvested 6 hours later for intracellular cytokine staining.
###end p 59
###begin title 60
Histological Examination
###end title 60
###begin p 61
###xml 30 34 <span type="species:ncbi:10090">mice</span>
The livers from Con A treated mice were harvested after 16 h and then fixed in 10% formalin, embedded in paraffin, sectioned and stained with hematoxylin and eosin for histological examination. Specimens were examined under a light microscope. 3-4 images were collected from each section and the injured area was measured with MCID Analysis 7.0 (Imaging Research Inc., Ontario, Canada).
###end p 61
###begin title 62
In vitro stimulation of purified CD4 cells with alpha-Galactosylceramide
###end title 62
###begin p 63
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 178 180 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 287 288 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 362 363 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 699 700 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 714 715 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 760 761 756 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 850 851 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 481 484 <span type="species:ncbi:10116">rat</span>
###xml 515 520 <span type="species:ncbi:10090">mouse</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
Spleens were harvested from 10-12 weeks old WT C57BL/6 and B7-1/2 mutant mice. Single cell suspension were treated for 45 min with 400 U ml-1 collagenase type IV and 50 microg ml-1 DNase I (Boehringer, Mannheim, Germany) before were incubated with anti-CD11c-coated magnetic beads. CD11c+ cells were positively selected according to the manufacturer's procedure (Miltenyi Biotec, Bergisch-Gladbach, Germany). Then all the flow-through was depleted with antibody mixture containing rat monoclonal antibodies against mouse CD45R (B220), CD11b (Mac1), CD16/32(2.4G2), CD11c (HB224) and CD8 (TIB210) according to manufacturer's manual (DYNAL, Oslo, Norway). Cell suspensions contained about 90% of CD11c+ cells and CD4+ cells respectively. After purification, 7x105 CD4 cells from either WT C57BL/6 or B7-1/2 mutant mice were co-cultured with 3x105 CD11c+ cells in 1ml Bruff's medium containing different concentration of alpha-Galactosylceramide (KRN7000). 48 hours later, the supernatant was harvest for the detection of secreted INF-gamma and IL-4 with ELISA. The relative amounts of cytokines were shown by absorbance read at 490nm (OD490nm).
###end p 63
###begin title 64
Statistical Analysis
###end title 64
###begin p 65
Data were statistically analyzed with two-tailed student T-test. P<0.05 is significant and p<0.01 is highly significant.
###end p 65
###begin p 66
We thank Lynde Shaw for her editorial assistance. Part of the study was carried out while the authors were at The Ohio State University.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells.
###end article-title 68
###begin article-title 69
CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
###end article-title 69
###begin article-title 70
###xml 39 45 <span type="species:ncbi:10090">murine</span>
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.
###end article-title 70
###begin article-title 71
The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
###end article-title 71
###begin article-title 72
T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
###end article-title 72
###begin article-title 73
Cytotoxic T lymphocytes to an unmutated tumor antigen P1A: normal development but restrained effector function.
###end article-title 73
###begin article-title 74
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Local costimulation reinvigorates tumor-specific cytolytic T lymphocytes for experimental therapy in mice with large tumor burdens.
###end article-title 74
###begin article-title 75
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis.
###end article-title 75
###begin article-title 76
ICOS co-stimulatory receptor is essential for T-cell activation and function.
###end article-title 76
###begin article-title 77
B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
###end article-title 77
###begin article-title 78
Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells.
###end article-title 78
###begin article-title 79
The NKT cell system: bridging innate and acquired immunity.
###end article-title 79
###begin article-title 80
The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
###end article-title 80
###begin article-title 81
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
CD1 recognition by mouse NK1+ T lymphocytes.
###end article-title 81
###begin article-title 82
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse CD1-specific NK1 T cells: development, specificity, and function.
###end article-title 82
###begin article-title 83
The unconventional lifestyle of NKT cells.
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo.
###end article-title 84
###begin article-title 85
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function.
###end article-title 85
###begin article-title 86
NKT cells and viral immunity.
###end article-title 86
###begin article-title 87
Regulation of antitumour immunity by CD1d-restricted NKT cells.
###end article-title 87
###begin article-title 88
Natural killer T cells as targets for immunotherapy of autoimmune diseases.
###end article-title 88
###begin article-title 89
Immunology. T before NK.
###end article-title 89
###begin article-title 90
Development and selection of NKT cells.
###end article-title 90
###begin article-title 91
NKT cells derive from double-positive thymocytes that are positively selected by CD1d.
###end article-title 91
###begin article-title 92
Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide.
###end article-title 92
###begin article-title 93
A thymic precursor to the NK T cell lineage.
###end article-title 93
###begin article-title 94
A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
###end article-title 94
###begin article-title 95
CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells.
###end article-title 95
###begin article-title 96
Liver NKT cells: an account of heterogeneity.
###end article-title 96
###begin article-title 97
Hepatic T cells and liver tolerance.
###end article-title 97
###begin article-title 98
To be or not to be NKT: natural killer T cells in the liver.
###end article-title 98
###begin article-title 99
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
###end article-title 99
###begin article-title 100
NKT cells are phenotypically and functionally diverse.
###end article-title 100
###begin article-title 101
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
###end article-title 101
###begin article-title 102
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
###end article-title 102
###begin article-title 103
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
###end article-title 103
###begin article-title 104
###xml 59 65 <span type="species:ncbi:10090">murine</span>
Critical contribution of liver natural killer T cells to a murine model of hepatitis.
###end article-title 104
###begin article-title 105
Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis.
###end article-title 105
###begin article-title 106
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology
###end article-title 106
###begin article-title 107
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
###end article-title 107
###begin article-title 108
SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo.
###end article-title 108
###begin article-title 109
Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes.
###end article-title 109
###begin article-title 110
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice.
###end article-title 110
###begin article-title 111
IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
###end article-title 111
###begin article-title 112
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Cytokine expression in three mouse models of experimental hepatitis.
###end article-title 112
###begin article-title 113
Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
###end article-title 113
###begin article-title 114
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Class I and II major histocompatibility complex gene product expression by a rat insulinoma cell line in vitro following exposure to gamma interferon.
###end article-title 114
###begin article-title 115
Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases.
###end article-title 115
###begin article-title 116
Activation and inhibition of lymphocytes by costimulation.
###end article-title 116
###begin article-title 117
Peripheral blockade of B7-1 and B7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work is supported by an NIH grant (AI 51342 to YL) and grants from the Department of Defense (DAMD17-03-1-0013 and W81XWH-07-1-0169 to PZ).
###end p 119

